Company intelligence / Profile preview
Ho Chai Kung
Sham Shui Po, Kowloon, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Ho Chai Kung is an established OTC brand in Hong Kong with strong market position in the analgesics category. The brand reported net profit of HK$38.7 million on sales of HK$85.2 million in FY15, with a net profit margin of 45.4%. As of FY2025, Ho Chai Kung delivered strong growth of 43.2% in branded medicines sales revenue, driven by sustained market momentum and expanded market penetration through targeted marketing initiatives.
- Therapeutic areas
- NeurologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
JBM (Healthcare) Limited (parent/owner)
Beyond the preview
Go deeper on Ho Chai Kung.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ho Chai Kung.